Skip to main content
. 2009 Oct;11(10):1084–1092. doi: 10.1593/neo.09814

Figure 6.

Figure 6

Overall curves in patients with lung adenocarcinoma harboring EGFR mutations according to the mutational status of KRAS assessed by ME-sequencing. Curve differences are statistically significant. The P value refers to log-rank test. Months indicate months from the beginning of treatment.